Condensed Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010
Net cash used in operating activities	$ (199,737)	$ (312,162)
Cash from investing activities:
Patent expenditures	(2,448)	(6,555)
Net cash used in investing activities	(2,448)	(6,555)
Cash from financing activities:
Proceeds from issuance of convertible note payable	103,000
Proceeds from notes payable – related party	70,000
Proceeds from exercise of options		8,200
Proceeds from sale of convertible preferred stock	18,000	85,500
Proceeds from sale of common stock	8,000	202,200
Net cash provided by financing activities	199,000	295,900
Net change in cash	(3,185)	(22,817)
Cash and cash equivalents at beginning of period	4,332	24,216
Cash and cash equivalents at end of period	1,147	1,399
Supplemental disclosure of cash flow information
Cash paid for interest	1,128	3,202
Cash paid for income taxes	0	0
Non-cash transactions:
Discount on convertible notes payable	$ 103,000